Clinical Trial Update: Safer Warfarin Treatment

View source ↗

Summary

A clinical trial evaluating safer warfarin treatment for conditions including atrial fibrillation and venous thromboembolism has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Coumadin (warfarin)
• JANTOVEN (WARFARIN SODIUM)
• Warfarin (warfarin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Atrial Fibrillation, Venous Thrombosis | Status: SUSPENDED